Biotech - Press Releases

Date	Title	Company
23-Nov-2020	Medicen Paris Region and IBEC join forces to create the first Bioengineering and Medtech Against Cancer event on November 24 and 25, 2020	Andrew Lloyd Associates
23-Nov-2020	Juergen Ernst to retire from Pharming's Board of Supervisory Directors after more than 11 years of distinguished service	Pharming Group N.V.
23-Nov-2020	Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies	Pierre Fabre and Y-Biologics
22-Nov-2020	Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19	U.S. Food and Drug Administration
20-Nov-2020	DNAtrix Announces Positive Data from Phase 2 CAPTIVE (KEYNOTE-192) Study with DNX-2401 in Patients with Recurrent Glioblastoma Highlighted in an Oral Late-Breaking Presentation During Society for Neuro-oncology (SNO) Annual Meeting	DNAtrix, Inc.
20-Nov-2020	SMi’s 2nd Annual AI in Drug Discovery Announces key industry speakers and agenda released	SMi Group
20-Nov-2020	Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development	Sosei Group Corporation
20-Nov-2020	Glycostem initiates phase I/IIa (pivotal) trial to evaluate the safety and efficacy of oNKord® in patients with Acute Myeloid Leukemia (AML)	Glycostem Therapeutics
20-Nov-2020	Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement	Eli Lilly and Company
20-Nov-2020	Cogent Biosciences to Participate in 3rd Annual Evercore ISI HealthCONx Virtual Conference	Cogent Biosciences, Inc.
20-Nov-2020	TheraCell Announces Royalty Milestone From Licensing	TheraCell, Inc.
20-Nov-2020	WPI-MANA Team: Biogenic Iron Sulfide Nanoparticles Enable Electron Uptake in Bacteria	International Center for Materials Nanoarchitectonics (WPI-MANA), National Institute for Materials Science (NIMS)
19-Nov-2020	Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19	U.S. Food and Drug Administration
19-Nov-2020	Natera Appoints Dr. Monica Bertagnolli to its Board of Directors	Natera, Inc.
19-Nov-2020	Allos Pharma secures exclusive license on arbaclofen in Fragile X Syndrome	Allos Pharma Inc.
19-Nov-2020	White Rock Capital Supports WaterMill's Case for Change at Ziopharm Oncology	White Rock Capital Partners, L.P.
19-Nov-2020	Elevar Therapeutics Presents Safety and Efficacy Results of Rivoceranib (apatinib) in Combination with Nivolumab at the 2020 Connective Tissue Oncology Society (CTOS) Annual Meeting	Elevar Therapeutics
19-Nov-2020	Neurocrine Biosciences to Present at Upcoming Healthcare Conferences	Neurocrine Biosciences, Inc.
19-Nov-2020	One week to go Webinar on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular Hiving™ Technology	SMi Group
19-Nov-2020	Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent	Bone Therapeutics